Shenyang Xingqi PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shenyang Xingqi PharmaceuticalLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥230.2M, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are CN¥2.2B and CN¥558.0M respectively. Shenyang Xingqi PharmaceuticalLtd's EBIT is CN¥389.8M making its interest coverage ratio -190.1. It has cash and short-term investments of CN¥503.3M.
Key information
14.1%
Debt to equity ratio
CN¥230.18m
Debt
| Interest coverage ratio | -190.1x |
| Cash | CN¥503.31m |
| Equity | CN¥1.63b |
| Total liabilities | CN¥558.01m |
| Total assets | CN¥2.19b |
Recent financial health updates
Recent updates
Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/E Is Still On The Mark Following 49% Share Price Bounce
Oct 23
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing
Sep 08With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case
Aug 19What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash
Jul 24Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?
Jun 28Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00
May 21After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar
May 10We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease
May 07Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump
Mar 15Financial Position Analysis
Short Term Liabilities: 300573's short term assets (CN¥947.7M) exceed its short term liabilities (CN¥483.3M).
Long Term Liabilities: 300573's short term assets (CN¥947.7M) exceed its long term liabilities (CN¥74.8M).
Debt to Equity History and Analysis
Debt Level: 300573 has more cash than its total debt.
Reducing Debt: 300573's debt to equity ratio has reduced from 15.9% to 14.1% over the past 5 years.
Debt Coverage: 300573's debt is well covered by operating cash flow (194.3%).
Interest Coverage: 300573 earns more interest than it pays, so coverage of interest payments is not a concern.